Activation of the Amyloid Cascade in Apolipoprotein E4 Transgenic Mice Induces Lysosomal Activation and Neurodegeneration Resulting in Marked Cognitive Deficits
Authors:
- Dimitri LevDLDimitri Lev
- Eliezer MasliahEMEliezer Masliah
- Daniel M. MichaelsonDMDaniel M. Michaelson
Open Access
- 30 April 2008
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 28 (18) , 4690-4701
Abstract
The allele E4 of apolipoprotein E (apoE4), the most prevalent genetic risk factor for Alzheimer's disease, is associated histopathologically with elevated levels of brain amyloid. This led to the suggestion that the pathological effects of apoE4 are mediated by cross-talk interactions with amyloid β peptide (Aβ), which accentuate the pathological effects of the amyloid cascade. The mechanisms underlying the Aβ-mediated pathological effects of apoE4 are unknown. We have shown recently that inhibition of the Aβ-degrading enzyme neprilysin in brains of wild-type apoE3 and apoE4 mice results in rapid and similar elevations in their total brain Aβ levels. However, the nucleation and aggregation of Aβ in these mice were markedly affected by the apoE genotype and were specifically enhanced in the apoE4 mice. We presently used the neprilysin inhibition paradigm to analyze the neuropathological and cognitive effects that are induced by apoE4 after activation of the amyloid cascade. This revealed that apoE4 stimulates isoform specifically the degeneration of hippocampal CA1 neurons and of entorhinal and septal neurons, which is accompanied by the accumulation of intracellular Aβ and apoE and with lysosomal activation. Furthermore, these neuropathological effects are associated isoform specifically with the occurrence of pronounced cognitive deficits in the ApoE4 mice. These findings provide the firstin vivoevidence regarding the cellular mechanisms underlying the pathological cross talk between apoE4 and Aβ, as well as a novel model system of neurodegenerationin vivothat is uniquely suitable for studying the early stages of the amyloid cascade and the effects thereon of apoE4.Keywords
This publication has 46 references indexed in Scilit:
- A Century of Alzheimer's DiseaseScience, 2006
- Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A amyloid pathwayBrain, 2006
- Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic ModelJournal of Neuroscience, 2005
- Apolipoprotein E4 Potentiates Amyloid β Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal CellsJournal of Biological Chemistry, 2002
- Role of apoE/Aβ interactions in Alzheimer's disease: insights from transgenic mouse modelsMolecular Psychiatry, 2002
- Specific Regional Transcription of Apolipoprotein E in Human Brain NeuronsThe American Journal of Pathology, 1999
- Hippocampal synaptic plasticity: role in spatial learning or the automatic recording of attended experience?Philosophical Transactions of the Royal Society B: Biological Sciences, 1997
- Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal CulturesJournal of Neurochemistry, 1997
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993